Volume 1, Issue 4

8 articles2021-11-30Vol. 1Issue 4XML
31
Jul
2021
Aptamer-Assisted Delivery of Nucleotides with Tumor-Suppressing Properties for Targeted Cancer Therapies
Review Article

Aptamer-Assisted Delivery of Nucleotides with Tumor-Suppressing Properties for Targeted Cancer Therapies

Pouya Safarzadeh KozaniORCID,
Pooria Safarzadeh KozaniORCID,
Fatemeh RahbarizadehORCID*
PDFFinal Published
18
Dec
2021
Insights into Background of Microbial Aggregations (Acinetobacter baumannii): A Century of Challenges
Review Article

Insights into Background of Microbial Aggregations (Acinetobacter baumannii): A Century of Challenges

Nafiseh Hosseinzadeh ShakibORCID,
Mohammad MotamedifarORCID*,
Yeganeh Sadeghi AslORCID
PDFFinal Published
2
Nov
2021
Single-Port Laparoscopic Appendectomy Performing by Emergency Operation: An Intervention Study in Vietnam
Research Article

Single-Port Laparoscopic Appendectomy Performing by Emergency Operation: An Intervention Study in Vietnam

Duc Minh Pham,
Vu Anh Pham,
Mai Tuyet Vi,
Linh Van Pham*
PDFFinal Published
19
Mar
2022
Assessment of Postdural Puncture Headache in Women Under Elective Cesarean Section: A Randomized Trial Study
Research Article

Assessment of Postdural Puncture Headache in Women Under Elective Cesarean Section: A Randomized Trial Study

Fatemeh JadidiORCID*,
Farzaneh Jadidi,
Saeed KhorramniaORCID,
Gholamreza BazmandeganORCID
PDFFinal Published
29
Mar
2022
Patients’ Anxiety in Coronary Care Unit: Comparison of Face-to-Face and Glass Visitation
Research Article

Patients’ Anxiety in Coronary Care Unit: Comparison of Face-to-Face and Glass Visitation

Hadi Bahrami,
Vahid Kheirandish*,
Kosar Mousavi,
Fatemeh Hosseini Nik,
Liley Mahmudi
PDFFinal Published
31
Aug
2021
The Current Health Challenges After More than One Year of COVID-19 Pandemic
Letter

The Current Health Challenges After More than One Year of COVID-19 Pandemic

Farahnaz KhajehnasiriORCID,
Mohsen PoursadeqiyanORCID*
PDFFinal Published
13
Mar
2022
Tebentafusp: The First FDA-approved Monoclonal Antibody for Cancer Treatment in 2022
Letter

Tebentafusp: The First FDA-approved Monoclonal Antibody for Cancer Treatment in 2022

Pouya Safarzadeh KozaniORCID,
Pooria Safarzadeh KozaniORCID,
Abdolkarim SheikhiORCID*
PDFFinal Published